SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading update

19 Jan 2022 07:00

RNS Number : 8735Y
Devro PLC
19 January 2022
 

19 January 2022

Devro plc

 

Trading update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the year ended 31 December 2021.

 

Revenue growth for the full year was encouraging with positive developments in volume, price and mix resulting in strong performances in both mature and emerging markets. 2021 constant currency revenue growth was circa 5%.

 

We anticipate 2021 operating profit performance to be in line with expectations, representing in excess of 10% constant currency growth, with earnings per share modestly ahead of current analyst expectations* due to a one-off tax benefit arising from the change in the UK corporate tax rate.

 

The Group also delivered strong cash generation in the final quarter. Net debt at the end of December 2021 was £90 million with net debt/EBITDA at circa 1.4x.

 

Devro will announce its results for the year ended 31 December 2021 on 2 March 2022.

 

*Company compiled consensus 2021 earnings per share average - 16.9p

 

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Rohan Cummings

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFWFWAEESELF
Date   Source Headline
1st Apr 20221:00 pmRNSBlock Listing Application
31st Mar 20229:57 amRNSDirector/PDMR Shareholding
25th Mar 20223:51 pmRNSAnnual Report & Accounts 2021 & Notice of 2022 AGM
2nd Mar 20227:00 amRNSFULL YEAR RESULTS
21st Jan 20223:17 pmRNSDirector/PDMR Shareholding
20th Jan 20225:39 pmRNSDirector/PDMR Shareholding
19th Jan 20225:23 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading update
16th Dec 202112:14 pmRNSHolding(s) in Company
23rd Nov 20217:00 amRNSTrading Update
2nd Nov 20217:00 amRNSDirectorate Changes
29th Sep 20218:00 amRNSNotice of ESG Seminar
24th Aug 20218:48 amRNSHolding(s) in Company
24th Aug 20218:47 amRNSHolding(s) in Company
12th Aug 20215:55 pmRNSHolding(s) in Company
4th Aug 202111:19 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
27th Jul 20214:57 pmRNSDirector/PDMR Shareholding
4th Jun 20219:05 amRNSDirector Declaration
5th May 20215:15 pmRNSDirector/PDMR Shareholding
4th May 20215:34 pmRNSDirector/PDMR Shareholding
29th Apr 20215:09 pmRNSResult of AGM
29th Apr 20217:00 amRNSTrading Update
15th Apr 20213:14 pmRNSDirector/PDMR Shareholding
13th Apr 20214:53 pmRNSDirector/PDMR Shareholding
26th Mar 20214:47 pmRNS2020 Annual Report and Notice of AGM
10th Mar 20215:04 pmRNSDirector/PDMR Shareholding
5th Mar 20214:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSFULL YEAR RESULTS
20th Jan 20219:29 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSTrading update
18th Dec 20202:12 pmRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSTrading Update
22nd Oct 20207:00 amRNSDirectorate Changes
14th Oct 20207:00 amRNSDirectorate Appointment
7th Oct 202010:16 amRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSDirector/PDMR Shareholding
29th Jul 20207:01 amRNSDirectorate Change
29th Jul 20207:00 amRNSHALF YEAR RESULTS
30th Jun 20207:00 amRNSAppointment of Corporate Broker
23rd Jun 20209:23 amRNSHolding(s) in Company
12th Jun 20208:27 amRNSDirector/PDMR Shareholding
15th May 202012:02 pmRNSPrice Monitoring Extension
12th May 202011:06 amRNSDirector/PDMR Shareholding
30th Apr 20202:39 pmRNSResult of AGM
29th Apr 20207:00 amRNSDirectorate Appointment
27th Apr 20204:54 pmRNSPublication of Articles of Association
27th Apr 20209:33 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSTrading Update
16th Apr 20204:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.